Abstract: The Other Side of the HIV Treatment Cascade: Using MOST to Develop a Cost-Effective Intervention to Improve Engagement in HIV Care and Treatment Among Black and Latino Persons Living with HIV (Society for Prevention Research 26th Annual Meeting)

433 The Other Side of the HIV Treatment Cascade: Using MOST to Develop a Cost-Effective Intervention to Improve Engagement in HIV Care and Treatment Among Black and Latino Persons Living with HIV

Schedule:
Friday, June 1, 2018
Columbia C (Hyatt Regency Washington, Washington, DC)
* noted as presenting author
Marya V. Gwadz, PhD, Senior Research Scientist, New York University, New York, NY
The other side of the HIV treatment cascade: Using MOST to develop a cost-effective intervention to improve engagement in HIV care and treatment among Black and Latino persons living with HIV

Introduction. More than half of persons living with HIV (PLWH) in the U.S. are insufficiently engaged in HIV care and not well established on antiretroviral therapy (ART); most are African American/Blacks and Latinos (AABL). A set of multi-level factors impede both HIV care and ART initiation with good adherence for AABL-PLWH, primary among them individual (e.g., substance use, distrust, fear), social (e.g., stigma), and structural-level barriers (e.g., difficulties accessing ancillary services). This study uses the MOST framework and a fractional factorial design to conduct an optimization trial examining five distinct, culturally appropriate intervention components, all grounded in self-determination and social-cognitive theories: counseling sessions, pre-adherence preparation, focused support groups, peer mentorship, and patient navigation.

Methods. Participants were recruited through a hybrid sampling approach including direct outreach in community-based organizations, media ads (free newspapers), and peer-to-peer recruitment. Eligibility criteria included age 18-65 years, African American/Black and Latino race/ethnicity, poor engagement in HIV care in the past year, taking ART ≤ 50% of the time or not at all in the past 6 weeks, and HIV viral load (VL) ≥ 1000 copies/mL. Participants completed a structured baseline interview on background and health factors, and then were randomly assigned to one of 16 experimental conditions, each comprised of a different combination of intervention components (most received 3-4 components). A randomly selected subset received qualitative interviews and all engaged in follow-up assessments (interviews, CD4, and HIV VL tests) at 4-, 8-, and 12-months post baseline.

Results. Peer-to-peer contact was the most effective recruitment method. Of the 72 participants enrolled to date, 34.7% were female; 69.4% African American/Black and 26.4% Latino; 61.7% of males and 12.0% of females were sexual minority; and participants were 46 years old on average (SD= 11 years). Serious vulnerabilities were common (e.g., 43.1% currently homeless, 59.7% incarcerated in the past, and 90.3% unemployed/disabled). Almost all (97.2%) took ART in the past (median 5 times stopping and re-starting ART). Past (84.7%) and current (40.3%) substance use problems were common. Intervention acceptability and retention were high. Preliminary qualitative and quantitative results, as well as lessons learned about administrating a factorial optimization trial with REDCap will be described.

Conclusions. AABH-PLWH “off the cascade” are challenging to locate, due to stigma, distrust, fear, and competing priorities. Study procedures and intervention components designed in keeping with self-determination theory can foster engagement, high retention, and intervention acceptability and efficacy. REDCap is an effective tool for managing a factorial optimization trial conducted in a field setting.